Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Valarie Blake"'
Autor:
Valarie Blake
Publikováno v:
Amsterdam Law Forum, Vol 3, Iss 1, Pp 25-29 (2011)
The latest advancement in reproductive medicine - reproductive tissue transplant - has come onto the scene, bringing with it great possibilities for the treatment of infertility but even more questions and challenges about regulation and ethics. Repr
Externí odkaz:
https://doaj.org/article/7abb6bcaad58456baf4951e73b49cdb4
Autor:
Valarie Blake
Publikováno v:
Laws, Vol 6, Iss 4, p 25 (2017)
Despite the importance of access to healthcare for the disabled, the Americans with Disabilities Act (ADA) has made little inroads in reducing disability-based discrimination by health insurers in the United States. One reason is undoubtedly the ADA
Externí odkaz:
https://doaj.org/article/9c1aebf4aecf492eb4fb2ebfddde894a
Autor:
Valarie Blake, Elizabeth Y. McCuskey
Publikováno v:
SSRN Electronic Journal.
Autor:
Valarie Blake
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
SSRN Electronic Journal.
Autor:
Valarie Blake, Michelle L. McGowan
Publikováno v:
The Journal of law, medicineethics : a journal of the American Society of Law, MedicineEthics. 48(3)
Federal law often avoids setting minimum standards for women’s health and reproductive rights issues, leaving legislative and regulatory gaps for the states to fill as they see fit. This has mixed results. It can lead to state innovation that impro
Autor:
Valarie Blake
Publikováno v:
Bioethics. 32:527-533
The first baby has successfully been born by uterus transplantation (UTx) in the United States and the procedure is swiftly becoming a viable clinical option for patients with uterine factor infertility (UFI). This raises a practical ethical question
Autor:
Mark L. Hatzenbuehler, Valarie Blake
Publikováno v:
Milbank Q
Policy Points Stigma is an established driver of population-level health outcomes. Antidiscrimination laws can generate or alleviate stigma and, thus, are a critical component in the study of improving population health. Currently, antidiscrimination
Publikováno v:
The Journal of Clinical Ethics. 27:219-226
Autor:
Valarie Blake
Publikováno v:
AMA Journal of Ethics. 15:687-691
Though there are channels through which terminally ill patients can access some experimental drugs that have not yet received FDA approval for marketing to the public, in general those drugs must already be proven safe and effective.